Skip to main content
Newsroom

Enveric Biosciences News

Media & Insights

Media Coverage

Enveric’s Patient-Centric Model to Enhance the Quality of Life of Cancer Patients [Benzinga]

https://www.benzinga.com/markets/penny-stocks/21/03/20317890/enverics-patient-centric-model-to-enhance-the-quality-of-life-of-cancer-patients

Jazz Leaps into Epilepsy with $7.2B Buyout of Cannabinoid Drugmaker GW Pharma [Fierce pharma]

https://www.fiercepharma.com/pharma/jazz-eyes-epilepsy-market-7-2b-buyout-cannabinoid-drugmaker-gw

Cannabis Stocks Rally Anew as $7 Billion GW Pharma Deal Spurs Interest in Weed and its Medical Benefits [MarketWatch]

https://www.marketwatch.com/story/cannabis-stocks-rally-anew-as-7-billion-gw-pharma-deal-spurs-interest-in-weed-and-its-medical-benefits-11612376529
Insights

What is Acute Myeloid Leukemia (AML)?

Leukemias are cancers of cells that would normally develop into different types of blood cells. There are several types of leukemia, which are classified based on their precursor cell line…
Enveric
September 24, 2019
Insights

What is Pancreatic Cancer?

The pancreas is an organ of the digestive and endocrine system located in the abdominal cavity behind the stomach. It helps to regulate several important hormones in the blood including…
Enveric
June 28, 2019

Medical cannabinoids (CBD) and brain tumours – Interview with Dr. Wai Liu (via Brain Tumour Research)

https://www.braintumourresearch.org/media/our-blog/blog-item/our-blog/2019/04/05/medical-cannabinoids-(cbd)-and-brain-tumours---interview-with-dr-wai-liu

Cannabis Executives Reveal The Industry’s 2019 Challenges And A Few Opportunities Too

https://www.forbes.com/sites/julieweed/2019/02/19/cannabis-executives-reveal-the-industrys-2019-challenges-and-a-few-opportunities-too/
Insights

The Early History of Cannabis

Cannabis has been used for thousands of years for industrial, recreational, religious, and medicinal purposes. Once valued as a versatile herbal medicine, cannabis has held a volatile place in the…
Enveric
December 10, 2018
Insights

What is Glioblastoma Multiforme?

Glioblastoma multiforme (GBM) is the most aggressive malignant tumor of the central nervous system. GBM arises from a specific type of glial cell called astrocytes, which support the survival and…
Enveric
November 12, 2018

Cannabidiol (CBD) oil as a treatment for brain tumours (via Brain Tumour Research)

https://www.braintumourresearch.org/media/our-blog/blog-item/our-blog/2018/10/05/cannabidiol-(cbd)-oil-as-a-treatment-for-brain-tumours

A compound in cannabis is ‘significantly’ effective in destroying cancerous tumours in leukaemia, study reveals (via The Daily Mail)

https://www.dailymail.co.uk/health/article-4573826/Cannabis-compound-kills-cancer-cells.html

Marijuana destroys leukemia cells, says totally chill new study (via Maxim)

https://www.maxim.com/news/cannabis-leukemia-2017-6

Cannabinoids used in sequence with chemotherapy are a more effective treatment for cancer, say experts (via Science Daily)

https://www.sciencedaily.com/releases/2017/06/170605085559.htm

Cannabinoids shown to enhance tumor-killing effects of chemotherapy drugs (via New Atlas)

https://newatlas.com/cannabinoids-cancer-treatment-with-chemotherapy/49899/

How pot helped shrink one of the most aggressive brain cancers (via The Washington Post)

https://www.washingtonpost.com/posteverything/wp/2014/11/18/how-pot-helped-shrink-one-of-the-most-aggressive-brain-cancers/

How cannabis was used to shrink one of the most aggressive brain cancers (via The Conversation)

https://theconversation.com/how-cannabis-was-used-to-shrink-one-of-the-most-aggressive-brain-cancers-34038

Media Contact

Caitlin Kasunich/Raquel Cona
KCSA Strategic Communications
EnvericBio@kcsa.com
(212) 896-1241

Subscribe to Receive News Alerts

Full Name
Email *
Select your notifications *
Sign Up for Updates

© 2021 Enveric Biosciences | Terms of Use | Privacy Policy

Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.